This specialty chemicals stock is in focus after H2 FY25 results - Details

Shares of Mumbai-based pharmaceutical and chemical manufacturing firm Sudarshan Pharma Industries Limited (SPIL) are in focus after the company released its H2 and full-year FY25 financial results. The specialty chemicals firm has posted a 45 per cent year-on-year rise in its net profit for the financial year 2024-25. The surge in the net profit was backed by export expansion, domestic sales and better margins from Active Pharmaceutical Ingredients (APIs) selling. 

Business